Hrt Financial »

Cytokinetics shares owned by Hrt Financial

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 43k 83.49
2022-12-31 $379k 8.3k 45.71
2021-06-30 $247k 13k 19.76

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Linde SHS (LIN)
Apple (AAPL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
CRH Ord (CRH)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Align Technology (ALGN)
Spdr S&p 500 Etf Tr Put
Home Depot (HD)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Hrt Financial

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics